Litcius/Paper detail

Influence of sarcopenia, clinical data, and 2-[18F] FDG PET/CT in outcome prediction of patients with early-stage adenocarcinoma esophageal cancer

Reut Anconina, Claudia Ortega, Ur Metser, Zhihui Amy Liu, Chihiro Suzuki, Micheal McInnis, Gail Darling, Rebecca Wong, Kirsty Taylor, Jonathan Yeung, Eric X. Chen, Carol J. Swallow, Jaspreet Bajwa, Raymond Woo-Jun Jang, Elena Elimova, Patrick Veit‐Haibach

2021European Journal of Nuclear Medicine and Molecular Imaging21 citationsDOI

Topics & Concepts

SarcopeniaMedicineStage (stratigraphy)Esophageal cancerAdenocarcinomaProportional hazards modelStandardized uptake valueLymphovascular invasionPositron emission tomographyInternal medicineRadiologyCancerNuclear medicineOncologyMetastasisBiologyPaleontologyEsophageal Cancer Research and TreatmentNutrition and Health in AgingInflammatory Biomarkers in Disease Prognosis
Influence of sarcopenia, clinical data, and 2-[18F] FDG PET/CT in outcome prediction of patients with early-stage adenocarcinoma esophageal cancer | Litcius